We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Monday
August 30
16:45 - 17:45
Room 1
Proffered papers 37: Immuno and targeted agents
Emmanouil Fokas, Germany;
Matthias Guckenberger, Switzerland
3580
Proffered papers
Clinical
16:45 - 16:55
Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas, Belgium
OC-0625
16:55 - 17:05
Toxicity of SRT combined with targeted agents: prospective analysis of the TOaSTT database
Stephanie Kroeze, Switzerland
OC-0626
17:05 - 17:15
A phase II trial of PD-1 inhibitor combined with Radiotherapy and GM-CSF (PRaG) in metastatic tumors
Yuehong Kong, China
OC-0627
17:15 - 17:25
Regional Control after Stereotactic Radiation therapy and Immunotherapy for NSCLC Brain Metastases
Judith Porte, France
OC-0628
17:25 - 17:35
A hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing radiotherapy
Nils Henrik Nicolay, Germany
OC-0629
17:35 - 17:45
Olaparib combined with radiotherapy for TNBC: 1-year toxicity report of the RADIOPARP phase 1 trial
Pierre Loap, France
OC-0630